Published in Biomacromolecules on August 11, 2007
Biocompatible hybrid nanogels. Small (2008) 0.84
Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment. Ther Deliv (2012) 0.83
Photo and redox dual responsive reversibly cross-linked nanocarrier for efficient tumor-targeted drug delivery. ACS Appl Mater Interfaces (2014) 0.82
The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev (2005) 7.56
Solvent effects on acrylate kp in organic media?-A systematic PLP-SEC study. Macromol Rapid Commun (2014) 1.97
Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol (2002) 1.79
Bioapplications of RAFT polymerization. Chem Rev (2009) 1.59
Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther Deliv (2011) 1.57
The generic enhancement of photochromic dye switching speeds in a rigid polymer matrix. Nat Mater (2005) 1.52
Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke (2002) 1.52
Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res (2004) 1.48
Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol (2003) 1.45
Revealing model dependencies in "Assessing the RAFT equilibrium constant via model systems: an EPR study". Macromol Rapid Commun (2011) 1.39
Novel CenterCross and MultiCross devices for the treatment of infrainguinal chronic total occlusions: initial single-centre experience. EuroIntervention (2016) 1.38
Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab (2010) 1.34
Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol (2005) 1.28
Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx (2005) 1.27
Well-defined protein-polymer conjugates via in situ RAFT polymerization. J Am Chem Soc (2007) 1.24
Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J Cereb Blood Flow Metab (2009) 1.22
Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J Neurochem (2009) 1.22
Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab (2010) 1.21
Smoking and ischemic stroke: a role for nicotine? Trends Pharmacol Sci (2002) 1.18
Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J Neurochem (2007) 1.18
An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents. Stroke (2012) 1.18
Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun (2005) 1.17
Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity. Stroke (2008) 1.15
Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin. Brain Res (2004) 1.13
Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem (2007) 1.12
Temperature-responsive self-assembled monolayers of oligo(ethylene glycol): control of biomolecular recognition. ACS Nano (2008) 1.09
Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci (2002) 1.09
RAFT and click chemistry: a versatile approach to well-defined block copolymers. Chem Commun (Camb) (2006) 1.08
Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem (2008) 1.07
Reversible siRNA-polymer conjugates by RAFT polymerization. Chem Commun (Camb) (2008) 1.06
Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation. Am J Physiol Heart Circ Physiol (2005) 1.06
Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Curr Pharm Des (2013) 1.03
Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr Pharm Des (2012) 1.03
CNS drug delivery: opioid peptides and the blood-brain barrier. AAPS J (2006) 1.02
Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier. J Pharmacol Exp Ther (2010) 1.02
Targeted drug delivery to treat pain and cerebral hypoxia. Pharmacol Rev (2013) 1.01
Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J Cell Sci (2003) 1.01
Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.00
An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway. J Neurosci (2013) 1.00
Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. Curr Pharm Des (2012) 0.98
Adaptable hetero Diels-Alder networks for fast self-healing under mild conditions. Adv Mater (2014) 0.97
P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia. J Neurochem (2012) 0.97
Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc Res (2007) 0.97
Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem (2005) 0.96
In situ formation of protein-polymer conjugates through reversible addition fragmentation chain transfer polymerization. Angew Chem Int Ed Engl (2007) 0.96
One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid- and reductant-sensitive crosslinked micelles. Biomacromolecules (2008) 0.94
Synthesis of various glycopolymer architectures via RAFT polymerization: from block copolymers to stars. Biomacromolecules (2006) 0.94
Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier. Brain Res (2008) 0.93
Predictive factors for longer length of stay in an emergency department: a prospective multicentre study evaluating the impact of age, patient's clinical acuity and complexity, and care pathways. Emerg Med J (2013) 0.92
Acid-degradable polymers for drug delivery: a decade of innovation. Chem Commun (Camb) (2013) 0.92
Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. Am J Physiol Heart Circ Physiol (2005) 0.91
Pain and the blood-brain barrier: obstacles to drug delivery. Adv Drug Deliv Rev (2003) 0.91
Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Res (2004) 0.90
RAFT polymerization and thiol chemistry: a complementary pairing for implementing modern macromolecular design. Macromol Rapid Commun (2011) 0.90
Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res (2006) 0.90
Poly(vinyl alcohol) star polymers prepared via MADIX/RAFT polymerisation. Chem Commun (Camb) (2004) 0.90
Core-cross-linked micelles synthesized by clicking bifunctional Pt(IV) anticancer drugs to isocyanates. Biomacromolecules (2010) 0.89
Consistent experimental and theoretical evidence for long-lived intermediate radicals in living free radical polymerization. J Am Chem Soc (2004) 0.89
Rapid UV light-triggered macromolecular click conjugations via the use of o-quinodimethanes. Macromol Rapid Commun (2011) 0.88
Efficient usage of thiocarbonates for both the production and the biofunctionalization of polymers. Macromol Rapid Commun (2009) 0.88
Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des (2014) 0.88
The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv (2014) 0.88
Polygalactose containing nanocages: the RAFT process for the synthesis of hollow sugar balls. Biomacromolecules (2009) 0.88
Synthesis and bioactivity of poly(HPMA)-lysozyme conjugates: the use of novel thiazolidine-2-thione coupling chemistry. Org Biomol Chem (2009) 0.87
New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. Clin Cancer Res (2005) 0.87
Synthesis of versatile thiol-reactive polymer scaffolds via RAFT polymerization. Biomacromolecules (2008) 0.86
Shell-cross-linked vesicles synthesized from block copolymers of Poly(D,L-lactide) and Poly(N-isopropyl acrylamide) as thermoresponsive nanocontainers. Langmuir (2004) 0.86
Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am J Physiol Heart Circ Physiol (2003) 0.86
Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. ACS Nano (2013) 0.86
One-pot synthesis and biofunctionalization of glycopolymers via RAFT polymerization and thiol-ene reactions. Chem Commun (Camb) (2009) 0.86
Degradable disulfide core-cross-linked micelles as a drug delivery system prepared from vinyl functionalized nucleosides via the RAFT process. Biomacromolecules (2008) 0.85
Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol (2003) 0.85
Thiol-yne and thiol-ene "click" chemistry as a tool for a variety of platinum drug delivery carriers, from statistical copolymers to crosslinked micelles. Biomacromolecules (2011) 0.85
Ultrafast click conjugation of macromolecular building blocks at ambient temperature. Angew Chem Int Ed Engl (2009) 0.85
Modification of polysaccharides through controlled/living radical polymerization grafting-towards the generation of high performance hybrids. Macromol Rapid Commun (2010) 0.85
Efficient synthesis of dendrimers via a thiol-yne and esterification process and their potential application in the delivery of platinum anti-cancer drugs. Chem Commun (Camb) (2009) 0.84
Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers. Mol Pharm (2013) 0.84
Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer. Biomater Sci (2014) 0.83
Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism. Mol Pharmacol (2013) 0.83
Diclofenac attenuates the regional effect of lambda-carrageenan on blood-brain barrier function and cytoarchitecture. J Pharmacol Exp Ther (2008) 0.83
Amphiphilic block copolymers based on poly(2-acryloyloxyethyl phosphorylcholine) prepared via RAFT polymerisation as biocompatible nanocontainers. Macromol Biosci (2004) 0.83
Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. Am J Physiol Heart Circ Physiol (2011) 0.83
Adding spatial control to click chemistry: phototriggered Diels-Alder surface (bio)functionalization at ambient temperature. Angew Chem Int Ed Engl (2011) 0.83
Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. EuroIntervention (2015) 0.83